Doing better with less: Can a quality improvement intervention to increase adherence to evidence-based cancer screening guidelines reduce health care costs?

Authors

null

Vineeth Sukrithan

Albert Einstein College of Medicine - Jacobi Medical Center, Bronx, NY

Vineeth Sukrithan , Alejandro Recio Boiles , Jose Nahun Galeas , Karenza Alexis , Tarek N. Elrafei , Marianna Strakhan

Organizations

Albert Einstein College of Medicine - Jacobi Medical Center, Bronx, NY, Albert Einstein College of Medicine - Jacobi Medical Center, New York City, NY

Research Funding

Other

Background: The cost of cancer care in the U.S. is projected to reach $158 billion by 2020. The ASCO Value in Cancer Care Task Force recently released a framework assessing the value of new cancer therapies based on benefits, toxicities, and costs. Reducing under and over-screening can improve the quality of cancer care while also reducing costs. Multiple studies have shown that adherence to U.S. Preventative Services Task Force (USPSTF) screening guidelines remains sub-optimal. We tested whether distributing a low-cost educational tool consisting of a Health Maintenance (HM) card among house staff of a large teaching hospital would impact adherence to updated cancer screening guidelines. We also calculated the potential impact on health care expenditure from this intervention. Methods: In January 2013, HM cards with USPSTF recommendations were posted in each Ambulatory Medicine clinic exam room. We assessed the adherence to screening guidelines by comparing a historical control of clinic visits from December 2012 (n = 336) to those from December 2013; a year after the intervention (n = 306). In order to calculate charges associated with screening procedures, Center for Medicare and Medicaid Services’ Physician Fee Schedule was used. Results: Adherence to USPSTF guidelines showed a significant increase of 40.8% (p < 0.01) for cervical, 33.2% (p < 0.01) for breast and 20.5% (p < 0.01) for colorectal cancer screening. Inappropriate screening actions were reduced by 26.8% (p < 0.01) for cervical and 32.8% (p < 0.01) for breast cancer. A non-significant 1.1% increase (p = 0.829) was observed for colorectal cancer. Based on the number of inappropriate screening procedures averted, we calculated annualized potential savings to the healthcare system amounting to $1,138,464 (95% CI; $680,640 - $1,597,140). Conclusions: The low-cost HM card increased appropriate cancer screening while reducing unnecessary testing and producing substantial savings to the healthcare system in a large urban cohort. In an era of expensive personalized cancer care, low cost-interventions to improve the quality of care delivery may help mitigate the burden on the health care system.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality of Care

Track

Health Services Research and Quality of Care

Sub Track

Quality Improvement

Citation

J Clin Oncol 34, 2016 (suppl; abstr 6590)

DOI

10.1200/JCO.2016.34.15_suppl.6590

Abstract #

6590

Poster Bd #

76

Abstract Disclosures

Similar Abstracts

First Author: John B. Kisiel

Abstract

2024 ASCO Quality Care Symposium

Quality improvement of breast and cervical cancer screening satisfaction rate at a resident-led clinic.

First Author: Eunbee Cho

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Use of novel cancer staging model to analyze healthcare costs of commercially insured patients with colorectal cancer.

First Author: Rebecca Smith

First Author: Nicole Ann Gay